The grant will support research to find guidelines for the management of children with NF1, determine clinical and molecular risk factors for the development of NF1, and develop immunotherapies, according to an April 4 CHOP news release.
NF1 is a genetic disorder that can lead to skin changes, skeletal abnormalities and tumors. The disorder affects 1 in 3,000 people.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
